Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$851M |
| 2 |
Apple
AAPL
|
+$663M |
| 3 |
UnitedHealth
UNH
|
+$206M |
| 4 |
Cisco
CSCO
|
+$192M |
| 5 |
Johnson & Johnson
JNJ
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$559M |
| 2 |
Broadcom
AVGO
|
+$224M |
| 3 |
United Rentals
URI
|
+$189M |
| 4 |
CRH
CRH
|
+$177M |
| 5 |
Pfizer
PFE
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.61% |
| 2 | Financials | 17.11% |
| 3 | Industrials | 13.24% |
| 4 | Consumer Discretionary | 11.1% |
| 5 | Healthcare | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Precigen
PGEN
$2.12B
| $85.2K | ﹤0.01% |
58,755
| – | – |
|
3277
OPAL Fuels
OPAL
$67.4M
| $84.6K | ﹤0.01% |
16,848
+4,954
| +42% | +$24.3K |
|
3278
Crexendo
CXDO
$221M
| $84.5K | ﹤0.01% |
17,571
+5,332
| +44% | +$29.6K |
|
|
LUMO
3279
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $83.5K | ﹤0.01% |
29,617
+14,053
| +90% | +$41.6K |
|
|
WHWK
3280
Whitehawk Therapeutics
WHWK
$190M
| $83.3K | ﹤0.01% |
35,595
| – | – |
|
3281
Great Elm Group
GEG
$68.4M
| $82.5K | ﹤0.01% |
42,955
-570
| -1% | -$1.09K |
|
|
WHLM
3282
DELISTED
Wilhelmina International, Inc
WHLM
| $81.6K | ﹤0.01% |
16,760
+2,303
| +16% | +$10.3K |
|
|
ICAD
3283
DELISTED
iCAD Inc
ICAD
| $81K | ﹤0.01% |
50,338
-47,522
| -49% | -$75.3K |
|
3284
Sono-Tek
SOTK
$80.6M
| $80.6K | ﹤0.01% |
16,491
+1,945
| +13% | +$10.5K |
|
3285
Energy Vault
NRGV
$513M
| $80.1K | ﹤0.01% |
+44,743
| New | +$78.2K |
|
3286
Tandy Leather Factory
TLF
$19.5M
| $79.9K | ﹤0.01% |
+17,178
| New | +$78.1K |
|
|
VCSA
3287
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $79.5K | ﹤0.01% |
11,651
| – | – |
|
3288
Usio Inc
USIO
$59.1M
| $78.9K | ﹤0.01% |
46,425
-8,857
| -16% | -$15.1K |
|
3289
Copel
ELPC
$8.77B
| $78.9K | ﹤0.01% |
11,722
+248
| +2% | +$1.82K |
|
3290
Trevi Therapeutics
TRVI
$2.61B
| $78.4K | ﹤0.01% |
+22,735
| New | +$50.7K |
|
3291
X4 Pharmaceuticals
XFOR
$377M
| $76.9K | ﹤0.01% |
1,843
| – | – |
|
3292
Cardiff Oncology
CRDF
$66.2M
| $75.9K | ﹤0.01% |
14,206
| – | – |
|
3293
Flexible Solutions
FSI
$64.1M
| $75.7K | ﹤0.01% |
40,247
-2,030
| -5% | -$3.81K |
|
|
ORKA
3294
Oruka Therapeutics
ORKA
$5.9B
| $75.7K | ﹤0.01% |
3,542
-1
| -0% | -$20 |
|
3295
Immix Biopharma
IMMX
$609M
| $75.3K | ﹤0.01% |
24,528
+12,613
| +106% | +$48.8K |
|
3296
Lightpath Technologies
LPTH
$648M
| $75.3K | ﹤0.01% |
54,543
| – | – |
|
3297
Clover Health Investments
CLOV
$2.29B
| $74.7K | ﹤0.01% |
94,128
| – | – |
|
3298
RAVE Restaurant Group
RAVE
$44.1M
| $74.5K | ﹤0.01% |
34,003
-4,148
| -11% | -$8.11K |
|
3299
OptimumBank Holdings
OPHC
$86.5M
| $73.6K | ﹤0.01% |
17,154
| – | – |
|
3300
One Stop Systems
OSS
$297M
| $72.6K | ﹤0.01% |
22,257
| – | – |
|
Similar funds
Dimensional Fund Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Dimensional Fund Advisors held 3,470 positions worth $369B, up 7.9% from $342B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 4.1%. Dimensional Fund Advisors opened 58 new positions and exited 83, leaving the 3,470-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2024 buy was Arcadium Lithium plc: 8,775,487 shares worth $37.8M.
- Dimensional Fund Advisors added most to NVIDIA in Q1 2024, an estimated $851M increase.
- Dimensional Fund Advisors's biggest Q1 2024 reduction was Meta Platforms (Facebook), cutting an estimated $559M.
- Dimensional Fund Advisors fully exited Textainer Group Holdings limited in Q1 2024, selling an estimated $161M.
- Dimensional Fund Advisors's ten largest holdings make up 13% of its $369B portfolio in Q1 2024.
- Dimensional Fund Advisors opened 58 new positions and closed 83 in Q1 2024.
- Dimensional Fund Advisors's portfolio value rose 7.9% quarter-over-quarter to $369B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2024, filed 10 May 2024.